Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Legacy Reserves Inc. - Common Stock (NY:LGCY)

10.48 +0.77 (+7.93%)
Official Closing Price Updated: 8:00 PM EST, Dec 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Legacy Reserves Inc. - Common Stock

News headline image
Legacy Education Inc (NYSEARCA:LGCY) Reports Q1 2026 Revenue Beat Driven by Enrollment Growth ↗
Legacy Education (LGCY) Q1 2026 earnings beat revenue estimates with strong growth driven by a surge in student enrollment. 
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
News headline image
A Preview Of Legacy Education's Earnings ↗
 
Via Benzinga
News headline image
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday. 
Via Benzinga
Topics Stocks
News headline image
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket ↗
Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announced it entered into a sales contract with Walker Times International for the sale of 10,000 units of... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Earnings Preview For Legacy Education ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 13, 2025 ↗
 
Via Benzinga
News headline image
4 Analysts Have This To Say About Legacy Education ↗
 
Via Benzinga
News headline image
Legacy Education Inc (NYSEARCA:LGCY) Stock Falls After Q4 Earnings Miss ↗
Legacy Education (LGCY) reported Q4 revenue beat but a significant EPS miss, causing the stock to drop nearly 10%. Full-year revenue grew 40%, yet the earnings miss overshadowed the strong growth. 
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For September 25, 2025 ↗
Companies Reporting Before The Bell • Accenture (NYSE: ACN) is likely to report quarterly earnings at $2.97 per share on revenue of $17.34 billion. 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
10 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 15, 2025 ↗
 
Via Benzinga
News headline image
No Fear And No Panic After A 10% Correction = No Bottom ↗
In this video lesson, I discuss the overall market, my books, and my game plan moving forward after Friday's ugly sell-off. 
Via Talk Markets
Topics Stocks / Equities
News headline image
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Self-Driving Startup Pony.ai Files For U.S. IPO ↗
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group... 
Via Talk Markets
Topics Initial Public Offering
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Obesity Drug Developer BioAge Makes Nasdaq Debut ↗
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.